세계의 환자 혈액 관리 시장 규모, 점유율, 성장 분석 : 제품별, 컴포넌트별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Patient Blood Management Market Size, Share, and Growth Analysis, By Product (Instruments, Blood Processing Devices), By Component (Whole Blood, Blood Components), By End User, By Region - Industry Forecast 2025-2032
상품코드:1780230
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 07월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
환자 혈액 관리 시장 규모는 2023년에 137억 9,000만 달러, 2024년 146억 6,000만 달러에서 2032년에는 239억 달러로 성장할 전망이며, 예측 기간(2025-2032년) CAGR은 6.30%를 보일 것으로 예측됩니다.
환자 혈액 관리(PBM) 시장은 PBM의 이점에 대한 인식이 높아지면서 만성 질환의 유병률 증가와 외과 수술의 급증에 힘입어 크게 성장하고 있습니다. 이 종합적인 접근 방식은 수혈이 필요한 환자의 치료를 강화하고 수혈에 대한 의존도를 최소화하면서 결과를 개선하는 것을 목표로 합니다. 주요 시장 성장 촉진요인으로는 일반적으로 수술이 필요한 심혈관 질환, 암 등의 질병 발생률 증가를 들 수 있습니다. 의료 서비스 제공업체는 수혈의 위험과 합병증을 줄이기 위해 PBM 전략에 집중하고 있습니다. 수술 성적 향상, 합병증 감소, 입원 기간 단축이 PBM 솔루션에 대한 수요를 촉진하고 있습니다. 수혈에 대한 대안을 촉진하고 환자의 혈액량을 최적화함으로써 PBM 관행은 전 세계 의료 프로토콜에 점점 더 많이 통합되고 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
환자 혈액 관리 시장 규모 : 제품별&CAGR(2024-2031)
시장 개요
기기
혈액 처리 장비
원심
혈액 세포 처리 장비
수혈 기기
아페레시스 장비
세포 회수 시스템
혈액 배양 스크리닝 장비
자동 혈액 배양 시스템
지원 기기
진단 및 검사 기기
중합효소 연쇄반응
혈액 분석 장비
혈액형 판정 장비
차세대 시퀀싱(NGS) 플랫폼
기타
혈액 보존 장비
냉장고
냉동고
액세서리
주사기 및 바늘
바이알 및 튜브
혈액백
기타 액세서리
시약 및 키트
배양용 배지
혈액형 판정 시약
슬라이드 염색
어세이 키트
기타
소프트웨어
혈액은행 및 수혈 소프트웨어
기타
환자 혈액 관리 시장 규모 : 컴포넌트별&CAGR(2024-2031)
시장 개요
전혈
혈액 성분
환자 혈액 관리 시장 규모 : 최종사용자별&CAGR(2024-2031)
시장 개요
병원
혈액은행
환자 혈액 관리 시장 규모 : 지역별&CAGR(2024-2031)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2023년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2021-2023년)
주요 기업 개요
Haemonetics Corporation(USA)
Macopharma(France)
Terumo Corporation(Japan)
B. Braun SE(Germany)
Grifols, S.A.(Spain)
Asahi Kasei Corporation(Japan)
BioMerieux SA(France)
LivaNova PLC(UK)
Fresenius Kabi AG(Germany)
Roche Holding AG(Switzerland)
Abbott Laboratories(USA)
Bio-Rad Laboratories, Inc.(USA)
Danaher Corporation(USA)
Siemens Healthineers(Germany)
Johnson & Johnson(USA)
Medtronic plc.(Ireland)
BD(Becton, Dickinson and Company)(USA)
Cardinal Health(USA)
Teleflex Incorporated(USA)
Stryker Corporation(USA)
결론과 제안
LSH
영문 목차
영문목차
Patient Blood Management Market size was valued at USD 13.79 Billion in 2023 and is poised to grow from USD 14.66 Billion in 2024 to USD 23.9 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).
The patient blood management market is witnessing substantial growth, propelled by rising chronic disease prevalence and a surge in surgical procedures, alongside heightened awareness of PBM benefits. This comprehensive approach enhances patient care for those requiring blood transfusions, aiming to improve outcomes while minimizing transfusion reliance. Key market drivers include the increasing incidence of conditions such as cardiovascular issues and cancers that typically necessitate surgery. Healthcare providers are gravitating towards PBM strategies to lessen transfusion risks and complications. The focus on enhancing surgical outcomes, reducing complications, and decreasing hospital stays fuels the demand for PBM solutions. By promoting alternatives to transfusions and optimizing patient blood volumes, PBM practices are becoming increasingly integrated into global healthcare protocols.
Top-down and bottom-up approaches were used to estimate and validate the size of the Patient Blood Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Patient Blood Management Market Segments Analysis
Global Patient Blood Management Market is segmented by product, component, end user and region. Based on product, the market is segmented into instruments, blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, blood storage devices, accessories, syringes & needles, vials & tubes, blood bags, other accessories, reagents and kits, culture media, blood typing reagents, slide staining, assay kits, others, software, blood bank and transfusion software and others. Based on component, the market is segmented into whole blood and blood components. Based on end user, the market is segmented into hospitals and blood banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Patient Blood Management Market
The transfusion medicine sector has seen remarkable advancements, characterized by the introduction of innovative techniques and technologies aimed at enhancing blood management. These developments have greatly elevated the safety and efficacy of blood transfusions, fostering a growing inclination towards implementing patient blood management practices. As healthcare providers increasingly recognize the benefits of these improvements, the demand for efficient blood management solutions continues to rise, ultimately leading to better patient outcomes. This ongoing evolution in blood transfusion methods is crucial in driving the overall growth of the patient blood management market.
Restraints in the Patient Blood Management Market
The adoption of patient blood management practices generally requires a shift away from traditional transfusion methods and established medical standards. This transition is met with challenges such as overcoming resistance to change, addressing the preferences of healthcare providers, and ensuring sufficient training and education for all involved parties. These factors can hinder the effective implementation and broader acceptance of patient blood management strategies, as stakeholders may be reluctant to abandon familiar procedures in favor of newer protocols aimed at improving patient outcomes. Overcoming these obstacles is essential for fostering a more efficient and effective patient care environment.
Market Trends of the Patient Blood Management Market
The global Patient Blood Management (PBM) market is witnessing a notable trend towards personalized and evidence-based strategies to enhance blood transfusion practices. This shift underscores the necessity of customizing transfusion protocols to align with individual patient profiles and clinical circumstances, moving away from a generic methodology. Healthcare institutions are increasingly aware of the associated risks of unnecessary blood transfusions-including transfusion reactions, infectious complications, and escalated healthcare expenses. Consequently, there is a growing investment in data analytics and technology solutions aimed at improving decision-making processes and ensuring optimal blood utilization, thereby transforming the PBM landscape into a more patient-centric approach.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Patient Blood Management Market Size by Product & CAGR (2024-2031)
Market Overview
Instruments
Blood Processing Devices
Centrifuge
Blood Cell Processors
Blood Transfusion Devices
Apheresis Machines
Cell Salvage Systems
Blood Culture Screening Devices
Automated Blood Culture Systems
Supporting Equipment
Diagnostic & Testing Instruments
Polymerase Chain Reaction
Hematology Analyzer
Blood Grouping Analyzers
Next-Generation Sequencing (Ngs) Platforms
Others
Blood Storage Devices
Refrigerator
Freezers
Accessories
Syringes & Needles
Vials & Tubes
Blood Bags
Other Accessories
Reagents And Kits
Culture Media
Blood Typing Reagents
Slide Staining
Assay Kits
Others
Software
Blood Bank And Transfusion Software
Others
Global Patient Blood Management Market Size by Component & CAGR (2024-2031)
Market Overview
Whole Blood
Blood Components
Global Patient Blood Management Market Size by End User & CAGR (2024-2031)
Market Overview
Hospitals
Blood Banks
Global Patient Blood Management Market Size & CAGR (2024-2031)
North America (Product, Component, End User)
US
Canada
Europe (Product, Component, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Component, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Component, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Component, End User)
